Mutated EGFR-IN-1 是用于突变 EGFR 抑制剂设计的有用中间体，例如 L858R EGFR、Exon19 缺失激活突变体和 T790M 抗性突变体。

Mutated EGFR-IN-1 is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant, and T790M resistance mutant.

Mutated EGFR inhibitor acts as egfr modulators useful for treating cancer.

1421372-66-8

C25H31N7O

445.56

Osimertinib analog;AZD9291中间体1

DMSO:≥ 75 mg/mL (168.33 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years